Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and supplemental oxygen for obstructive sleep apnoea
ACTRN12616001297415Phase 2Completed
- Sponsor
- Monash University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetazolamide and oxygen in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Monash University. Primary endpoint: Loop gain from clinical polysomnography. Started Sep 2018; status: completed.
02
Drugs
acetazolamideoxygen
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12616001297415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001297415.